Physician profile
George S Edwards
NPI 1851552608
$1,719.88
in general payments reported to CMS, 2019-2025
15 companies · $699 in 2025
The $699 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.59 · 2020: $28.70 · 2021: $79.57 · 2022: $263 · 2023: $207 · 2024: $380 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $697 · Food and Beverage: $554 · Education: $35.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $697.11 |
| Food and Beverage | $554.04 |
| Education | $35.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tricoast Surgical Solutions LLC | $900.26 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $247.01 | 2021-2023 | Xiaflex |
| Stryker Corporation | $115.34 | 2024-2025 | Tornier Perform Reversed Glenoid, Gamma, Aequalis Perform |
| Endo USA, INC. | $107.62 | 2024-2025 | Xiaflex |
| Amgen INC. | $64.68 | 2025 | Krystexxa |
| Skeletal Dynamics INC | $59.01 | 2021 | |
| Sonex Health, INC. | $45.06 | 2022-2023 | Sx-One Microknife |
| Depuy Synthes Sales INC. | $34.98 | 2019 | |
| Arthrosurface Incorporated | $25.63 | 2019-2020 | |
| Abbott Laboratories | $25.00 | 2022 | |
| Arthrex, INC. | $24.00 | 2025 | |
| Integra Lifesciences Corporation | $21.18 | 2022 | |
| Bioventus LLC | $20.43 | 2022 | |
| Daiichi Sankyo INC. | $16.55 | 2020 | |
| Axogen | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.